𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Histiocytosis X with involvement of brain

✍ Scribed by Joseph Rubé; Samuel de la Pava; John W. Pickren


Publisher
John Wiley and Sons
Year
1967
Tongue
English
Weight
923 KB
Volume
20
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Bone marrow involvement in histiocytosis
✍ McClain, K. ;Ramsay, N. K. C. ;Robison, L. ;Sundberg, R. D. ;Nesbit, M. 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB

Twenty-eight patients with histiocytosis X (HX) who had bone marrow aspirates andlor trephine biopsies taken at diagnosis were studied. Five of the 28 patients (18%) had bone marrow specimens with clusters of benign histiocytes characteristic of histiocytosis X. Several statistically significant cli

Etoposide in the treatment of six childr
✍ Viana, Marcos Borato ;Oliveira, Benigna Maria ;Silva, Celia Maria ;Leite, Virgin 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB

Six children received etoposide as the single agent for treatment of Langerhans cell histiocytosis (LCH; histiocytosis X). Five were less than 2 years old at diagnosis. All had multiorgan involvement; one had liver and pulmonary dysfunction. Two infants also had clinical signs of immune deficiency.

The treatment of advanced histiocytosis-
✍ Thomas W. Griffin 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

A patient with systemic histiocytosis was treated with hemibody irradiation, vincristine, and prednisone. The patient died of an extensive peripheral neuropathy. An autopsy revealed gross histiocytosis-X involvement of the unirradiated tissues, and no evidence of disease within the field of irradiat

“Etoposide in the treatment of six child
✍ Whitlock, James A. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Viana et al. [I] described their experience with etoposide (VP-16) as initial therapy in the management of patients with Langerhans cell histiocytosis (LCH). However, caution should be used in advocating the use of an epipodophyllotoxin as the "drug of choice" for the treatment of this disorder. Alt